← FDA Drug Approvals (Drugs@FDA)

LYRFIGTU

NDA · New Drug Application · Sponsor: ELEVAR THERAPEUTICS INC · Approved 2026-09-23

Drug application

FDA Application #

NDA220425

Application type

New Drug Application

Brand name

LYRFIGTU

Generic name

Lirafugratinib Hydrochloride

Active ingredients

LIRAFUGRATINIB HYDROCHLORIDE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

ELEVAR THERAPEUTICS INC

First approval

2026-09-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown